Patients and Methods This study was a part of an exploratory analysis of a sample of COPD patients evaluating the relationship between fatigue and serum biomarkers of autoimmunity. Initially we demonstrated that in patients with COPD the presence of fatigue is associated with worse health status, lung function and exercise capacity.The protocol of this clinical study was approved by the Ethics Committee of the University of Medicine and Pharmacy `Gr. T. Popa` Iași, România. Participants who were willing to participate based on signed informed consent were subsequently enrolled. Inclusion criteria for COPD patients consisted of: COPD diagnosis known for at least one year, absence of systemic corticosteroids in the therapeutic regimen during the …show more content…
This questionnaire has several subdomain scores including Vitality, Physical Functioning or Emotional Role Functioning and two component scores Physical (SF-PCS) respectively Mental (SF-MCS), the scores ranging from 0 (worst possible) to 100 (best possible) [10]. In this study, SF-36 was used to compare HRQoL in both populations and in particular, to detect the presence of the clinically significant fatigue: this is defined with scores for Vitality subdomain of 50 or less. This cut-off being validated in other autoimmune debilitating diseases such as multiple sclerosis or rheumatoid arthritis [11-13]. Health status (HS) was evaluated only in COPD patients with the disease-specific Clinical COPD Questionnaire (CCQ). This has a 10 items and three domain scores for symptoms (CCQ-S), mental status (CCQ-M)and functional status (CCQ-F), and it also has a total score (CCQ-T) [14]. Higher scores are associated with worse health
The study began with 32 patients having stages II to IV COPD. They had to meet the criteria pertaining to the Global Initiative for Chronic Obstructive Pulmonary Disease; total lung capacity >120%, (FEV1/FVC) <70%, FEV1 <80%, RV/TLC >140% and >40% of predicted values in stable conditions. Patients were removed from the study if they had asthma, heart failure, orthopedic impairments of the shoulder girdle, recent surgery, past thoracic fractures, pneumothorax, and claustrophobia.
Accordingly, to this information of COPD: Coping with COPD from PubMed Health, this article provides the early stages, progression, coping and emergency plan and this disease affects family and friends. It is written answering the question, what to expect from COPD and how to manage this lung disease? A team of health care professionals, scientists and editors, and experts (Chronic obstructive pulmonary disease (COPD), 2015), provides education of how this disease may affect daily lives, how to live with this disease and what causes
The study included 100 patients with COPD. All patients fulfilled the inclusion and exclusion criteria. According to its demographic and clinical parameters and treatment groups differ among themselves. Completed the study, all patients included in the study. The therapy in all patients with a clinically meaningful improvement of symptoms was observed.
Chronic obstructive pulmonary disease (COPD) is major leading cause of morbidity and mortality in United States. There are some risk factors for COPD like age and smoking and other illnesses, often leading COPD patients to present with multiple coexisting comorbidities. COPD exacerbations and comorbidities plays a major role in the overall severity in individual’s health. The management and the medical intervention in COPD patients with comorbidities need a holistic approach. All of the health care specialists in COPD management need to work together with professionals specialized in the management of the other chronic diseases in order to provide a multidisciplinary approach to COPD patients with multiple diseases. A patient M. A. 72 years
Rationale: L.J. exhibits symptoms of COPD that include shortness of breath and productive cough. He has a smoking history of 65-pack-year and smoking has been identified as the primary cause/trigger of the disease (Nagelmann et al., 2011).
Chronic obstructive pulmonary disease (COPD) is preventable disease that has a detrimental effects on both the airway and lung parenchyma (Nazir & Erbland, 2009). COPD categorises emphysema and chronic bronchitis, both of which are characterised by a reduced maximum expiratory flow and slow but forced emptying of the lungs (Jeffery 1998). The disease has the one of the highest number of fatalities in the developed world due to the ever increasing amount of tobacco smokers and is associated with significant morbidity and mortality (Marx, Hockberger & Walls, 2014). Signs and symptoms that indicate the presence of the disease include a productive cough, wheezing, dyspnoea and predisposing risk factors (Edelman et al., 1992).
Diagnosing COPD is multifactorial, as stated previously, an all-encompassing nursing assessment and patient history must be conducted. When these processes are finalized, and subjective evidence points towards COPD, it is necessary to confirm the diagnosis with objective data. The definitive way to do this is by conducting pulmonary function testing (PFT); specifically, spirometry. On top of diagnosing, spirometry, is also pertinent for staging the patients COPD (Corbridge,et al., 2012). In addition to these facets, there are several other radiologic and laboratory tests that are helpful in determining the severity of COPD; they are not so much diagnostic, as they are informative.
The prognosis of COPD is variable, depending on how bad the COPD is. “Some people with very mild COPD, if they can stop smoking and they can take of themselves, shouldn’t have any shortened life expectancy” (Rodriguez & Sohrabi, 2015). Those with moderate to severe COPD or who developed the disease at an earlier age tend to have more issues as they grow older. By taking a proactive approach and being open to asking for help and support, you can effectively manage COPD (Rodrigues & Sohrabi,
COPD can affect the psychological wellbeing of the sufferer. Before Mr Woods condition deteriorated he was able to go out, he used to enjoy going fishing with his sons and playing with his grandchildren. Because of his condition, Mr Woods is prone to feelings of inadequacy and depression. He also feels guilty because of his growing dependency on his wife for the simplest of daily tasks such as making a cup of tea or answering the door.
The impact of knowledge and education on coping strategies, disease management, symptoms to report, and mental health have been shown to improve HRQOL in the older adult COPD patient. Especially in a disease that is not curable, it is incumbent on medical professionals to understand how to positively impact HRQOL. Addressing patients’ needs from a physical perspective, while taking into account the psychological aspects, allows for a more potent, effective, holistic impact. Most often, the St. George’s Respiratory Questionnaire (SGRQ) will be used to measure HRQOL in older patients with COPD.
COPD is an abbreviated term for the lung disease Chronic Obstructive Pulmonary Disease and it is seen in people everyday. It is estimated that this disease affects roughly 24 million individuals in the U.S.. Chronic Obstructive Pulmonary Disease occurs in other countries instead of just the United States. It is increasing rapidly and therapies currently do not alter the disease (Gross “Abstract”). Chronic Obstructive Pulmonary Disease can be caused by smoking, environmental factors and or genetic factors, which are the top three risk factors for this disease (COPD Foundation). Although it can be genetic, it is mostly caused by inhaling pollutants.This disease may be slightly treated if not all the way by different breathing techniques and medications. COPD is a lung disease that worsens as it progresses to the point that it may be life threatening, but it can be prevented by staying away or using caution around pollutants such as harsh fumes and cigarette smoke.
“Elicit from the client their personal goals for improved quality of life” (Carpenito, 2013). This can help us start our path of identifying, eliminating or reducing contributing complications. Gia thinks this is a three part priority for nursing assessments for identifying complications of COPD. First, a complete health history with a pack-year smoking history. This helps to understand the extent of the damage done to the elastin in the lungs. Next, the physical assessment is done and is just as important. We listen to breath sounds in all lung areas, heart rate and rhythm, inspect chest for barrelling and nail beds for clubbing. The last most important assessment is the lab assessment. Here we see ABGs and assess sputum. We can tell if there is respiratory acidosis and if it is being compensated by the kidneys. We can tell by the sputum if there is any other infection in the lungs increasing the
This report will examine the definition and causes of Chronic Obstructive Pulmonary Disease (COPD). It will identify conditions associated with the disease and identify risk factors and particular high risk groups. Finally, it will identify and evaluate relevant health promotion campaigns set up to reduce the frequency and seriousness of occurrence.
The disease is quite common, affecting millions of Americans, and has forced its way all the way up to being the third leading cause of death in the U.S. Consequently, COPD is also associated with significant hardships in other aspects of life. Adults with COPD may have limitations during activities of daily living such as walking or climbing stairs (CDC, 2016). They may be unable to work and might require special equipment such as oxygen tanks (Wheaton et Al. 2013). They may present with other chronic diseases such as arthritis, CHF, diabetes, CHD, stroke, or asthma (Cunningham et al. 2015). Alongside those hardships, they may
Chronic fatigue syndrome (CFS) is a complex and serious illness that is often misunderstood. Experts have noted that the terminology “chronic fatigue syndrome” can trivialize this illness and stigmatize persons who experience its symptoms. However, the fatigue in this illness is striking and quite distinct from the common fatigue everyone experiences. A variety of other names have been used, including myalgic encephalomyelitis (ME), ME/CFS, chronic fatigue immune dysfunction, and most recently, systemic exertion intolerance disease. The lack of agreement about nomenclature need not be an impediment for advancing critically needed research and education.19,20,21